MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Covagen enters into a strategic research collaboration and license agreement with Mitsubishi Tanabe for the development of bispecific FynomAbs.
Brennan CaruthersOctober 17, 2012
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury.

Brennan CaruthersOctober 25, 2012
Next

Genocea Closes $30 Million in Series C Financing. The Bill & Melinda Gates Foundation and CVF join as new investors.

Brennan CaruthersOctober 10, 2012

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact